is semaglutide a sglt2 inhibitor Addition of Ozempic to improves hyperglycemia and bodyweight Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors:

Langade D, Thakare V, Kanchi S, Kelgane S

References Davies MJ, Drexel H, Jornayvaz FR, Pataky Z, Seferovi PM, Wanner C (2022) Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes

Inject into fatty tissue using a fine-gauge insulin needle

Bifidobacterium with the role of 5-hydroxytryptophan synthesis regulation alleviates the symptom of depression and related microbiota dysbiosis

5 WARNINGS AND PRECAUTIONS Directions And Dosage 2 DOSAGE AND ADMINISTRATION 3 DOSAGE FORMS AND STRENGTHS Injection: clear, colorless solution available as follows: Single-Dose Pens Dose per Injection Total Strength per Total Volume 0.25 mg 0.25 mg/0.5 mL 0.5 mg 0.5 mg/0.5 mL 1 mg 1 mg/0.5 mL 1.7 mg 1.7 mg/0.75 mL 2.4 mg 2.4 mg/0.75 mL 7.2 mg (WEGOVY HD) 7.2 mg/0.75 mL Single-Patient-Use Pen (4 doses per Pen) (WEGOVY FlexTouch) Dose per Injection Total Strength per Total Volume 2.4 mg 9.6 mg/3 mL (3.2 mg/mL) Single-Dose Syringes Dose per Injection Total Strength per Total Volume 0.25 mg 0.25 mg/0.5 mL 0.5 mg 0.5 mg/0.5 mL 1 mg 1 mg/0.5 mL 1.7 mg 1.7 mg/0.75 mL 2.4 mg 2.4 mg/0.75 mL Tablets: available as: Tablet Strength Description 1.5 mg White to light yellow, round shaped debossed with 1.5 on one side and novo on the other side 4 mg White to light yellow, round shaped debossed with 4 on one side and novo on the other side 9 mg White to light yellow, round shaped debossed with 9 on one side and novo on the other side 25 mg White to light yellow, oval shaped debossed with 25 on one side and novo on the other side 10 OVERDOSAGE Overdoses have been reported with other GLP-1 receptor agonists